Merck Company Stock Analysis

Merck Stock Analysis Notes

About 80.0% of the company shares are owned by institutional investors. The book value of Merck was now reported as 20.85. The company has Price/Earnings To Growth (PEG) ratio of 0.8. Merck Company recorded earning per share (EPS) of 7.7. The entity last dividend was issued on the 16th of March 2026. The firm had 1048:1000 split on the 3rd of June 2021. Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 67000 people. To find out more about Merck Company contact Kenneth Frazier at 908 740 4000 or learn more at https://www.merck.com.

Merck Company Investment Alerts

Merck Largest EPS Surprises

View All Earnings Estimates

Merck Environmental, Social, and Governance (ESG) Scores

Merck Thematic Classifications

Merck Stock Institutional Investors

Note, although Merck's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Merck Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 275.43 B.

Merck Profitablity

The company has Net Profit Margin of 0.3 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.41 %, which entails that for every 100 dollars of revenue, it generated $0.41 of operating income.

Management Efficiency

Merck Company has Return on Asset of 0.1376 % which means that on every $100 spent on assets, it made $0.1376 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3949 %, implying that it generated $0.3949 on every 100 dollars invested. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to 0.18. The value of Return On Capital Employed is expected to slide to 0.24. At this time, Merck's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 141.4 B this year, although the value of Change To Liabilities will most likely fall to (476.3 M).

Technical Drivers

As of the 1st of February, Merck secures the Mean Deviation of 1.28, risk adjusted performance of 0.1644, and Downside Deviation of 1.37. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Merck Company, as well as the relationship between them.

Merck Company Price Movement Analysis

Merck Company Insider Trading Activities

Merck Outstanding Bonds

Merck Predictive Daily Indicators

Merck Corporate Filings

Merck Forecast Models

Merck's time-series forecasting models are one of many Merck's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Merck's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Merck Bond Ratings

Merck Company financial ratings play a critical role in determining how much Merck have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Merck's borrowing costs.

Merck Company Debt to Cash Allocation

Merck Company has 38.27 B in debt with debt to equity (D/E) ratio of 0.68, which is OK given its current industry classification. Merck Company has a current ratio of 1.43, which is typical for the industry and considered as normal. Nevertheless, prudent borrowing could serve as an effective mechanism for Merck to finance growth opportunities yielding strong returns.

Merck Total Assets Over Time

Merck Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Merck uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Merck Debt Ratio

31.0

It seems about 69% of Merck's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Merck's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Merck, which in turn will lower the firm's financial flexibility.

Merck Corporate Bonds Issued

Merck Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Merck prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Merck shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Merck. By using and applying Merck Stock analysis, traders can create a robust methodology for identifying Merck entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Merck analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Merck analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Merck Company stock analysis indicators help investors evaluate how Merck stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Merck shares will generate the highest return on investment. By understating and applying Merck stock analysis, traders can identify Merck position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. Expected growth trajectory for Merck significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Merck assessment requires weighing all these inputs, though not all factors influence outcomes equally.

Understanding Merck Company requires distinguishing between market price and book value, where the latter reflects Merck's accounting equity. The concept of intrinsic value—what Merck's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Merck's price substantially above or below its fundamental value.

Understanding that Merck's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merck represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Merck's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.